Kite Pharma, Inc.: income_tax_expense
| Value | {"amount": 0, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} |
|---|---|
| Period | 2015-01-01 – 2015-12-31 |
| Status | current |
| Entity | Kite Pharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fd6a7aba-5a53-48df-b90b-42fccac6fa6a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001510580-17-000003 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510580/income-tax-expense/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fd6a7aba-5a53-48df-b90b-42fccac6fa6a
History
- supersedes {"amount": 1000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} (evidence 0001564590-16-013699)